Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

iTAPP Declares Radiometer’s AQT90 FLEX a ‘High Impact Innovation’

Published: Wednesday, November 06, 2013
Last Updated: Wednesday, November 06, 2013
Bookmark and Share
AQT90 FLEX analyzer’s advanced technology allows rapid, laboratory standard testing.

Radiometer’s AQT90 FLEX immunoassay analyzer has been identified by the Innovative Technology Adoption Procurement Programme (iTAPP) as being significant to the NHS Quality, Innovation, Productivity and Prevention (QIPP) agenda, with the benefits it offers to the wider health economy being explored at local, regional and national level.

Diagnosis and treatment of patients presenting to emergency departments, coagulation clinics or early pregnancy units is highly dependent on prompt receipt of pathology results.

The AQT90 FLEX analyzer’s advanced technology allows rapid, laboratory standard testing of a comprehensive panel of cardiac markers, as well as D-dimer, CRP and β-hCG, at the point of care.

The fully automated process uses a closed tube system, eliminating time-consuming manual sample preparation and reducing the risk of staff coming into contact with biological fluids.

Accurate results are consistently generated in less than 20 minutes, enabling faster diagnosis and treatment, and prompt clinical decision making.

This capability - allowing clinicians to quickly rule in or out conditions such as acute coronary syndrome, congestive heart failure, DVT, pulmonary embolisms, acute infections and pregnancy - significantly improves productivity, and patient management and outcomes.

The AQT90 Briefing Pack, published through the NHS Technology Adoption Centre, has been fully integrated into the NICE Health Technologies Adoption Programme, providing comprehensive documentation that demonstrates how the system can yield real, significant and sustainable benefits for local healthcare services.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
New Regulator of Immune Reaction Discovered
Calcium signal in cell nucleus regulates not only many brain functions but also defence reactions of the immune system.
First Steps to Neutralising Zika
Researchers have discovered a highly potent antibody that neutralises Zika infection at a cellular level.
Cell’s ‘Built-In Circuit’ Help Prevent Tumour Growth
Researchers have created cells with a 'built-in genetic circuit' that inhibits tumour growth.
Factors Behind Suppression of Stem Cell Mobilization Revealed
The findings could lead to improvements in transplantation therapy.
Common Virus Helps Fight Liver Cancer
Reovirus, a cause of childhood colds, stimulates the immune system to kill cancerous cells.
Antibody Protects Mice from Zika Infection
Researchers develop human-derived antibody protected pregnant mice and their developing fetuses from Zika infection.
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
T Cell Channel Could Be Targeted to Treat Cancers
Researcher identify ion-channel found within T cells that could be targeted to reduce development of neck and head cancers.
Targeting Pancreatic Cancer
Cutting-edge technology exploits cancer cells’ vulnerabilities to develop new treatments.
A Genome-wide View of Human DNA Viruses
In this study, Duplex sequencing was used to accurately analyse the genome-wide rate of spontaneous mutation of human adenovirus C5 (HAdv5).
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!